MedCity News

MARCH 4, 2024

The latest Akero data build on six-month results reported in 2022. Akero Therapeutics’ preliminary Phase 2b data show that treatment with its MASH drug, efruxifermin, continued to distance itself from a placebo measured at nearly two years of treatment.

Leads 113

Leads Biopharma Pharma 113

European Pharmaceutical Review

OCTOBER 27, 2022

Elements leading to a rational design of cyclodextrin-based formulations. The post Drug Formulation In-Depth Focus 2022 appeared first on European Pharmaceutical Review. Colin Freund, Chief Executive Officer of Modra Pharmaceuticals, reveals the benefits of this emerging generation of anticancer treatment.

Pharmaceutical 98

Pharmaceutical Leads 98

European Pharmaceutical Review

NOVEMBER 11, 2022

The American Heart Association (AHA)’s Scientific Sessions 2022 is a global exchange of the latest advancements in research and clinical practice of cardiovascular science. The fibrils prevent ordinary organ function and can lead to progressive organ failure. Baxdrostat – treating hypertension drug-resistance. Hypertension.

Safety 118

Safety Patients Medical Transportation 118

Pharmaceutical Technology

DECEMBER 27, 2022

The healthcare industry saw its share of ups and downs in 2022. With the help of government data, Andrew Hillman and Manasi Vaidya investigated how the uneven rollout of these antivirals across the US was leading to scarcity in many places, and how the demand for the much-favoured Paxlovid was not being met. . See you in 2023!

Healthcare 122

Healthcare Healthcare Pharma Medical 122

pharmaphorum

OCTOBER 14, 2022

— Circular Digital Health (DiCE project) (@circular_health) October 13, 2022. The post Janssen leads effort to cut waste in digital health devices appeared first on. Great to have you on board @ForumWeee , we look forward to the next four years of collaboration! Photo by Possessed Photography on Unsplash.

Leads 123

Leads Electronics Ethics Healthcare 123

European Pharmaceutical Review

NOVEMBER 16, 2022

Bayer joined the top ten for the first time, with the broad geographic reach of its R&D plans highlighted as a best practice in the 2022 Index. 2022 Access to Medicine Index findings. The post Big Pharma leading in access-to-medicine strategies, shows data appeared first on European Pharmaceutical Review.

Medicine 98

Medicine Leads Pharma Manufacturing 98

Pharmaceutical Technology

FEBRUARY 21, 2023

Pfizer and BioNTech’s Covid-19 vaccine, Comirnaty, had a phenomenal year with forecast sales of $37bn in 2022. Comirnaty is the leading prophylactic vaccine for Covid-19 and is expected to generate an additional $2.8bn in sales in 2022 compared to GlobalData’s H1 2022 forecast.

Sales 98

Sales Government Leads Medicine 98

Clarivate

FEBRUARY 27, 2024

When global trademark filing activity fell in 2022 , questions rose around what this signified. Applications from Mainland China were up by 9% compared with 2022, while Polish applicants filed 19% more EUTM applications than in 2022. Mainland China – 21,701 (up by 9% compared to 2022) 2.

Marketing 98

Marketing Leads Management 98

European Pharmaceutical Review

JULY 26, 2022

Under exceptional circumstances Nulibry * (fosdenopterin) was given a positive opinion for the treatment of molybdenum cofactor deficiency type A, an ultra-rare condition that appears shortly after birth and leads to brain injury and death. This product was designated as an orphan medicine during its development.

Medicine 105

Medicine Marketing Patients Safety 105

Clarivate

JUNE 28, 2022

Today we release the 2022 update to the annual Journal Citation Reports (JCR). This year’s JCR release is based on 2021 data compiled from the Web of Science Core Collection , the leading collection of quality journals, books and conference proceedings in the world’s largest publisher-neutral global citation database.

Medicine 141

Medicine Government Leads Medical 141

Clarivate

NOVEMBER 15, 2022

The exceptional individuals designated Highly Cited Researchers 2022 have published multiple highly cited papers, ranking in the top 1% by citations for field and year over the last decade. Celebrating Highly Cited Researchers 2022. Of all the world’s researchers, they are one in 1,000. Research fuels the race for knowledge.

Government 111

Government Distribution Recruitment Leads 111

Clarivate

SEPTEMBER 21, 2022

As of September 2022, 64 of the Citation Laureates named by the Institute for Scientific Information (ISI) at Clarivate went on to receive a Nobel Prize, more than half within three years of being named on our lists. The ongoing impact of our 2022 Citation Laureates. 01%) have been cited 2,000 or more times.

Electronics 111

Electronics Medicine Leads Medical 111

Clarivate

NOVEMBER 18, 2022

To coincide with the 17th G20 Heads of State and Government Summit taking place in Bali, Clarivate has released its Annual G20 Scorecard – Research Performance 2022. . While GDP has increased by 60% between 2012 and 2020, GERD has doubled in the same period, leading to an increase by a quarter in GERD by GDP.

Government 98

Government Medicine Distribution Management 98

European Pharmaceutical Review

JUNE 24, 2022

2022 is probably the biggest year in EU pharmaceutical law that I have seen in 30 years. 2022 is undeniably a critical year for change in the pharmaceutical industry: for the first time in several decades, the European Union (EU)’s pharmaceutical legislation is up for review. ORPHAN DRUG REPORT 2022 [Internet]. Future outlook.

Pharmaceutical 105

Pharmaceutical Medicine Marketing Competition 105

Spotio

JUNE 6, 2022

Sales Prospecting Statistics The way companies prospect for leads is changing. HubSpot] 9 in 10 companies use 2+ lead enrichment tools to learn more about prospects. Invest in a toolset that allows you to quickly build profiles and find accurate lead data in your target market. Well, the data suggests otherwise.

Sales 111

Sales Prospecting B2B Sales Leads 111

Fierce Pharma

MAY 6, 2024

Following Nucleus RadioPharma’s 2022 debut, the GE HealthCare- and Mayo Clinic-backed radiopharmaceuticals CDMO is ready to put its production thesis to the test. The production deal will support ARTBIO’s planned phase 1 and 2 clinical trials of its lead program in prostate cancer, AB001.

Manufacturing 130

Manufacturing Healthcare Healthcare Leads 130

Clarivate

JANUARY 3, 2023

The latest annual edition, Research Fronts 2022, marks the 9th collaboration between Clarivate and the CAS. Moving beyond early descriptions of the SARS-CoV-2 virus and its clinical course, the 2022 Research Fronts chronicle the ongoing search for effective vaccines and treatments. Read the new report now. Fields and nations.

Specialization 98

Specialization Side effects Management Medicine 98

PM360

AUGUST 9, 2022

Data from brief medication questionnaires can lead to overestimated adherence, given the info is self-reported, but can also result in valuable insights regarding attitude, barriers, influence, and other behavioral attributes.

Medical 105

Medical Patients Electronics Healthcare 105

MedCity News

NOVEMBER 15, 2023

Gilead Sciences is increasing its stake in partner Arcellx and expanding the cell therapy alliance the companies started in 2022. The deal expands the lead partnered program to more cancers and gives Gilead a chance at another Arcellx cell therapy candidate made with different technology.

Leads 114

Leads Biopharma Pharma 114

European Pharmaceutical Review

JANUARY 18, 2024

There were 175 ongoing trials in 2023, compared to 178 in 2022. According to the CGT Catapult database, the UK has also stayed an attractive location for commercial trials, accounting for 81 percent of these trials in 2023 and 80 percent in 2022. This is a notable increase from 168 in 2021, CGT Catapult highlighted.

Distribution 111

Distribution Manufacturing Medicine Government 111

European Pharmaceutical Review

MAY 31, 2023

The inventory position of 28 major pharmaceutical manufacturers in 2022 has been revealed in an annual report. Inventories grew to a combined total of $150bn in 2022, the analysis showed. Sales grew by seven percent, totalling $994 billion in 2022. The cost of sales increased by four percent to $311 billion.

Management 111

Management Pharma Pharmaceutical manufacturing Medicine 111

European Pharmaceutical Review

JANUARY 9, 2023

Global M&A activity in 2022. The global life sciences mergers and acquisitions (M&A) investment totalled $105 billion in the first 11 months of 2022, with total deal value well down on 2021. EY’s research observed an overall drop in 2022 M&A investment worldwide. Biopharma alone held over $1.4

Biopharma 98

Biopharma Specialization Leads Competition 98

Pharmaceutical Technology

JUNE 12, 2023

In 2022, the FDA awarded VX-548 breakthrough therapy and fast-track designations for post-operative pain, and the drug is forecast to reach sales of $416m by 2029. Currently, there are 546 painkillers in active development, with 458 targeting opioid-receptor alternatives, according to GlobalData’s Drugs Database.

Medical 143

Medical Prescription Management Manufacturing 143

European Pharmaceutical Review

MARCH 5, 2024

” According to BeiGene, since joining BeiGene in 2022 as the Global Head of Operational Excellence, De la Rocha has “championed impactful changes in clinical development, driving compliance, productivity, and efficiency.” Pilar de la Rocha’s career journey to date Pilar de la Rocha as Head of Europe, Global Clinical Operations, Beigene.

Medicine 98

Medicine Leads Medical Manufacturing 98

Pharmaceutical Technology

JUNE 7, 2023

Eli Lilly has achieved significant gains in the past quarter, leading to it becoming the most valuable pharmaceutical company in the world, with a market cap of $420bn, surpassing Johnson & Johnson. There have been several Phase III trials for Mounjaro, with SURMOUNT-1 demonstrating a weight loss of up to 22.5%

Leads 98

Leads Marketing FDA Sales 98

PM360

JANUARY 7, 2025

Acquisition highlights companies shared commitment to clients, workplace culture, and attracting the industrys best people TORONTO, ON/SARATOGA SPRINGS, NY January 7, 2025 Klick Health today announced it has acquired Peregrine Market Access, a leading market access strategy and value communications specialist in life sciences.

Marketing 52

Marketing Leads Medical Consulting 52

European Pharmaceutical Review

DECEMBER 22, 2022

This milestone follows the agreement in principle between Moderna and the UK Government, announced in June 2022. Steve Barclay, Health and Social Care Secretary added: “By boosting our onshore vaccine manufacturing capability, we are a step closer to becoming the leading global hub for life sciences. Moderna, Inc.

Manufacturing 131

Manufacturing Government Leads Pharmaceutical 131

European Pharmaceutical Review

OCTOBER 5, 2023

Maja Pedersen has been appointed as Chief Quality Officer (CQO), to lead FUJIFILM Diosynth Biotechnologies’ global quality team. She explained: “I am thrilled to be joining FUJIFILM Diosynth Biotechnologies again and becoming an integral part of leading our teams to develop and embed a transformational quality culture.” “We

Recruitment 105

Recruitment Manufacturing Biopharma Leads 105

European Pharmaceutical Review

FEBRUARY 14, 2024

billion in 2022, the research expected that the market will reach a CAGR of 4.2 The research specified that the parenteral administration sector accounted for more than half of the global pharmaceutical suspension market in 2022. billion by 2032. Having valued $55.5 percent between 2023 and 2032.

Pharmaceutical 95

Pharmaceutical Marketing Medicine Healthcare 95

European Pharmaceutical Review

JANUARY 3, 2023

“Despite advances, there remains a high unmet need for those with heavily pretreated multiple myeloma as only 30 percent of triple-class exposed patients respond to currently available treatment options,” commented (Res) Dr Edmond Chan, Senior Director EMEA Therapeutic Area Lead Haematology, Janssen-Cilag Limited.

Marketing 98

Marketing Food and Drug Administration Medicine Food 98

European Pharmaceutical Review

SEPTEMBER 12, 2023

Although core to the new EU GMP Annex 1 1 – mentioned more than 50 times in the 2022 version of the document – contamination control strategies are not new. Opening the session, moderator Tim Sandle highlighted six fundamental aspects of contamination control. Early adopters started putting these strategies together around 20 years ago.

Consulting 128

Consulting Biopharma Manufacturing Pharmaceutical 128

European Pharmaceutical Review

MAY 12, 2023

Innovative therapies for rare diseases The acquisition will help to drive the growth of CTI’s lead product, kinase inhibitor VONJO ® (pacritinib) “in treating myeloproliferative disease,” stated Dr Adam Craig, President, Chief Executive Officer and Interim Chief Medical Officer of CTI BioPharma.

Food and Drug Administration 105

Food and Drug Administration Biopharma Medicine Food 105

PM360

OCTOBER 25, 2022

Galen Growth , a leading digital health, data-driven market intelligence company, and FINN Partners , a global integrated marketing services agency, announced a joint effort to mine data and produce the first “Global State of Digital Health Report.” Additional quarterly reports are anticipated throughout the coming year.

Marketing 98

Marketing Leads Healthcare Healthcare 98

European Pharmaceutical Review

JANUARY 15, 2023

Moderna has joined the Association of the British Pharmaceutical Industry (ABPI) , the UK’s leading pharmaceutical industry body. In December 2022, Moderna announced it had finalised a strategic partnership with the UK government. In January 2022, Gilead joined the ABPI. Moderna’s long-term commitment to UK investment.

Pharmaceutical 110

Pharmaceutical Manufacturing Medicine Government 110

World of DTC Marketing

FEBRUARY 19, 2021

Included in the programmatic ad errors is Pfizer, who developed a leading COVID vaccine. It was estimated that the costs related to digital advertising fraud worldwide would grow exponentially within the four years between 2018 and 2022, from 19 billion to 44 billion U.S. When will pharma stop using programmatic online ads?

Pharma 180

Pharma Media Leads Marketing 180

European Pharmaceutical Review

SEPTEMBER 29, 2022

Most ISRs were mild to moderate in severity and none lead to premature discontinuation from the study. There were no life threatening TEAEs, TEAEs leading to premature discontinuation of study, serious adverse events (SAEs) or deaths. PPD is an extremely common psychological condition affecting women after labour.

Pharmacology 105

Pharmacology Leads Patients Management 105

Pharmaceutical Technology

APRIL 20, 2023

The firm reported 47% growth in sales from Q2 to Q4 in 2022, which is testament to CBC’s unique and effective investor-operator strategy. “We This financing round follows Hasten’s acquisition of the Chinese mainland exclusive rights for five cardiovascular and metabolism drugs from Takeda Pharmaceutical in March 2022.

Biopharma 98

Biopharma Healthcare Healthcare Sales 98